导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 12.80% | 217/826 |
| 近一周 | -2.40% | 622/874 |
| 近一月 | -2.00% | 279/873 |
| 近一季 | -2.50% | 299/865 |
| 近半年 | 8.39% | 220/845 |
| 近一年 | 14.18% | 253/802 |
| 近两年 | 70.60% | 291/736 |
| 近三年 | 71.04% | 126/659 |
| 成立以来 | 127.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.75% 620/1070 |
30.11% 315/1101 |
- - |
- - |
| 2025 | 37.04% 368/1065 |
9.06% 180/1014 |
2.96% 438/1038 |
27.08% 410/1050 |
-3.97% 663/1065 |
| 2024 | 21.92% 74/1011 |
12.10% 13/960 |
7.24% 42/983 |
5.39% 870/991 |
-3.77% 589/1011 |
| 2023 | -2.79% 152/952 |
1.51% 540/880 |
0.22% 176/895 |
2.88% 23/915 |
-7.12% 690/952 |
| 2022 | -26.08% 532/867 |
-20.95% 573/773 |
10.86% 234/806 |
-23.83% 796/845 |
10.75% 68/867 |
| 2021 | -13.63% 506/740 |
-0.55% 172/580 |
9.61% 366/659 |
-13.38% 582/704 |
-8.53% 645/740 |
| 2020 | 36.01% 323/554 |
-11.29% 391/419 |
26.54% 172/466 |
7.45% 313/517 |
12.77% 261/554 |
| 2019 | 36.93% 245/410 |
16.68% 978/1146 |
-0.08% 345/1228 |
3.38% 237/390 |
13.61% 81/410 |
| 2018 | -21.40% 96/349 |
- - |
0.28% 74/990 |
-9.19% 715/1000 |
-11.50% 471/1080 |
| 2017 | 49.79% 4/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 广发沪港深新起点股票A VS. 东吴新产业精选股票A(580008) |